Alice Markussen
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.
Journal: BMC medicine
Published: February 04, 2026
Cholangiocarcinoma in Denmark: time trends in mortality following resection.
Journal: International journal of surgery (London, England)
Published: May 14, 2025
Prognosis related to treatment plan in patients with biliary tract cancer: A nationwide database study.
Journal: Cancer epidemiology
Published: July 01, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2024
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
Journal: Cancers
Published: December 13, 2022
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.
Journal: Frontiers in oncology
Published: June 07, 2022
Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study.
Journal: Oncology
Published: March 23, 2017
Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer.
Journal: Oncology
Published: February 22, 2017
Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer.
Journal: Clinical colorectal cancer
Published: February 29, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026